Follow The Filings

TNGX position history

The shares of Tango Therapeutics (TNGX) that FARALLON CAPITAL MANAGEMENT, L.L.C. reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 300,000 shares, $3.9M, 0.02% of portfolio
  2. 2021 Q4: 300,000 shares, $3.3M, 0.02% of portfolio
  3. 2022 Q1: 300,000 shares, $2.3M, 0.01% of portfolio
  4. 2022 Q2: 300,000 shares, $1.4M, <0.01% of portfolio
  5. 2022 Q3: 300,000 shares, $1.1M, <0.01% of portfolio
  6. 2022 Q4: 270,000 shares, $2M, 0.01% of portfolio, Reduce −10.0%
  7. 2023 Q1: not held, Exit
  8. 2023 Q2: not held
  9. 2023 Q3: not held
  10. 2023 Q4: not held
  11. 2024 Q1: not held
  12. 2024 Q2: not held
  13. 2024 Q3: not held
  14. 2024 Q4: 4,000,000 shares, $12M, 0.06% of portfolio, New
  15. 2025 Q1: 4,610,930 shares, $6.3M, 0.04% of portfolio, Add +15.3%
  16. 2025 Q2: 9,157,000 shares, $47M, 0.20% of portfolio, Add +98.6%
  17. 2025 Q3: 21,514,000 shares, $181M, 0.74% of portfolio, Add +134.9%
  18. 2025 Q4: 13,061,411 shares, $116M, 0.55% of portfolio, Reduce −39.3%
  19. 2026 Q1: 9,097,411 shares, $190M, 1.1% of portfolio, Reduce −30.3%
  20. 2026 Q2: 12,277,000 shares, $384M, 1.8% of portfolio, Add +35.0%
  21. 2026 Q3: 4,550,688 shares, $114M, 0.49% of portfolio, Reduce −62.9%
Holdings date Value % of holdings Shares Filing date All 13F holders